ConductScience.org, home

Paper29907809

Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.

Shimoni A and 13 others. Leukemia, 2019. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide. Papers, record 29907809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29907809

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.
PubMed
Journal
Leukemia
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
1.87
iCite
Revised in PubMed
2026-10-10
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shimoni AAvichai
2Labopin MMyriam
3Lorentino FFrancesca
4Van Lint MTMaria Teresa
5Koc YYener
6Gülbas ZZafer
7Tischer JJohanna
8Bruno BBenedetto
9Blaise DDidierhttps://orcid.org/0000-0002-5684-9447
10Pioltelli PPietro
11Afanasyev BBoris
12Ciceri FFabio
13Mohty MMohamad
14Nagler AArnon

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CyclophosphamideMajor topic
Graft vs Host DiseaseMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Killer Cells, NaturalMajor topic
Leukemia, Myeloid, AcuteMajor topic
Precursor Cell Lymphoblastic Leukemia-LymphomaMajor topic
Receptors, KIRMajor topic
Adult
Aged
Female
Follow-Up Studies
Histocompatibility
Humans
Immunosuppressive Agents
Male
Middle Aged
Prognosis
Retrospective Studies
Survival Rate
Transplantation Conditioning
Transplantation, Haploidentical
Young Adult

Source PubMed

Download CSV of topics

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119961944Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.Biol Blood Marrow Transplant2010https://conductscience.org/library/papers/19961944PubMed
228986344NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.Blood2018https://conductscience.org/library/papers/28986344PubMed
324319201Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL.Hematology Am Soc Hematol Educ Program2013https://conductscience.org/library/papers/24319201PubMed
419167686Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.Biol Blood Marrow Transplant2009https://conductscience.org/library/papers/19167686PubMed
511896281Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.Science2002https://conductscience.org/library/papers/11896281PubMed
622892554Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies.Biol Blood Marrow Transplant2013https://conductscience.org/library/papers/22892554PubMed
728558762Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.J Hematol Oncol2017https://conductscience.org/library/papers/28558762PubMed
825949893Situational aldehyde dehydrogenase expression by regulatory T cells may explain the contextual duality of cyclophosphamide as both a pro-inflammatory and tolerogenic agent.Oncoimmunology2015https://conductscience.org/library/papers/25949893PubMed
926130705Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.Blood2015https://conductscience.org/library/papers/26130705PubMed
1027071449How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?J Hematol Oncol2016https://conductscience.org/library/papers/27071449PubMed
1121045194NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation.Blood2011https://conductscience.org/library/papers/21045194PubMed
1226305035Modern approaches to HLA-haploidentical blood or marrow transplantation.Nat Rev Clin Oncol2016https://conductscience.org/library/papers/26305035PubMed
1327788762Selecting the best haploidentical donor.Semin Hematol2016https://conductscience.org/library/papers/27788762PubMed
1419925877Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.Biol Blood Marrow Transplant2010https://conductscience.org/library/papers/19925877PubMed
1516131567KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation.Blood2005https://conductscience.org/library/papers/16131567PubMed
1625263628Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.Biol Blood Marrow Transplant2014https://conductscience.org/library/papers/25263628PubMed
1721703971Conflicting impact of alloreactive NK cells on transplantation outcomes after haploidentical transplantation: do the reconstitution kinetics of natural killer cells create these differences?Biol Blood Marrow Transplant2011https://conductscience.org/library/papers/21703971PubMed
1817371948Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.Blood2007https://conductscience.org/library/papers/17371948PubMed
1910204198Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.Stat Med1999https://conductscience.org/library/papers/10204198PubMed
2028287639Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.Bone Marrow Transplant2017https://conductscience.org/library/papers/28287639PubMed

See all 36 referencesDownload CSV of references

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
42712389Contrasting relapse rate associated with the absence of HLA-A3/A11 in T cell-replete haploidentical transplantation.Front Immunol2026https://conductscience.org/library/papers/42712389PubMed
42292451Editorial: NK cells in transplantation.Front Immunol2026https://conductscience.org/library/papers/42292451PubMed
40934005Prediction and effect on relapse of natural killer cell alloreactivity based on KIR-HLA interactions in pediatric haploidentical transplantation with anti-thymoglobulin.Front Immunol2025https://conductscience.org/library/papers/40934005PubMed
40810334
Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation.
Br J Haematol2025https://conductscience.org/library/papers/40810334PubMed
40710344Natural Killer (NK) Cell Alloreactivity in Haploidentical Stem Cell Transplantation.Cells2025https://conductscience.org/library/papers/40710344PubMed
39737173Impact of inhibitory KIR ligand mismatch and other variables on outcomes following myeloablative posttransplant cyclophosphamide-based T-cell-replete haploidentical bone marrow transplantation.Front Immunol2024https://conductscience.org/library/papers/39737173PubMed
38964919[The impact of donor human leukocyte antigen-Bw4 allele on natural killer cell reconstitution and transplant-related mortality in haploidentical transplantation].Zhonghua Xue Ye Xue Za Zhi2024https://conductscience.org/library/papers/38964919PubMed
38903503Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation.Front Immunol2024https://conductscience.org/library/papers/38903503PubMed
38889342Future directions in haploidentical hematopoietic stem cell transplantation.Hematology2024https://conductscience.org/library/papers/38889342PubMed
38817602The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation.Front Immunol2024https://conductscience.org/library/papers/38817602PubMed
37228595NK cell defects: implication in acute myeloid leukemia.Front Immunol2023https://conductscience.org/library/papers/37228595PubMed
36311784Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy.Front Immunol2022https://conductscience.org/library/papers/36311784PubMed
35994137The Role of NK Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia.Stem Cell Rev Rep2023https://conductscience.org/library/papers/35994137PubMed
35022535The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML.Bone Marrow Transplant2022https://conductscience.org/library/papers/35022535PubMed
34778077Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective.Front Oncol2021https://conductscience.org/library/papers/34778077PubMed
34595443Haploidentical Hematopoietic Stem Cell Transplantation Followed by 'Post-Cyclophosphamide': The Future of Allogeneic Stem Cell Transplant.Clin Hematol Int2020https://conductscience.org/library/papers/34595443PubMed
34413848Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia.Front Immunol2021https://conductscience.org/library/papers/34413848PubMed
33674791Contemporary haploidentical stem cell transplant strategies in children with hematological malignancies.Bone Marrow Transplant2021https://conductscience.org/library/papers/33674791PubMed
33496734Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide.Blood Adv2021https://conductscience.org/library/papers/33496734PubMed
33193367Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.Front Immunol2020https://conductscience.org/library/papers/33193367PubMed

See all 34 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
KIR2DL43805PubTator's text mininghttps://conductscience.org/library/genes/3805

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29907809

GET https://conductscience.org/api/papers/v1/29907809/references?page=2